Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Hull

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Exploration of Targeted Anti-Tumor Therapy|November 19, 2020
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancerMilene Volpato, Michele Cummings, Abeer M Shaaban, et al.
Lancet (London, England)|November 24, 2018
Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trialMark A Hull, Kirsty Sprange, Trish Hepburn, et al.
Oncotarget|April 9, 2016
Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasisMilene Volpato, Sarah L Perry, Gemma Marston, et al.
Frontline Gastroenterology|January 18, 2019
Attitudes to out-of-programme experiences, research and academic training of gastroenterology trainees between 2007 and 2016Michael McFarlane, Neeraj Bhala, Louise China, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 26, 2022
The COLO-COHORT (Colorectal Cancer Cohort) study: Protocol for a multi-centre, observational research study and development of a consent-for-contact research platformJames S Hampton, Sara Koo, Christina Dobson, et al.
The Journal of Pathology|August 14, 2013
MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasionEldo T Verghese, Ruth Drury, Caroline A Green, et al.
Scientific Reports|July 22, 2017
Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc <sup>Min/+</sup> mouse model of intestinal tumorigenesisMark A Hull, Richard J Cuthbert, C W Stanley Ko, et al.
Gut|September 28, 2017
A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiotaHenry Watson, Suparna Mitra, Fiona C Croden, et al.
International Journal of Cancer|January 10, 2019
Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance)Mingyang Song, Fang-Shu Ou, Tyler J Zemla, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2023
Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention TrialJohn R Davies, Tracey Mell, Harriett Fuller, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Exploration of Targeted Anti-Tumor Therapy|November 19, 2020
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancerMilene Volpato, Michele Cummings, Abeer M Shaaban, et al.
Lancet (London, England)|November 24, 2018
Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trialMark A Hull, Kirsty Sprange, Trish Hepburn, et al.
Oncotarget|April 9, 2016
Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasisMilene Volpato, Sarah L Perry, Gemma Marston, et al.
Frontline Gastroenterology|January 18, 2019
Attitudes to out-of-programme experiences, research and academic training of gastroenterology trainees between 2007 and 2016Michael McFarlane, Neeraj Bhala, Louise China, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 26, 2022
The COLO-COHORT (Colorectal Cancer Cohort) study: Protocol for a multi-centre, observational research study and development of a consent-for-contact research platformJames S Hampton, Sara Koo, Christina Dobson, et al.
The Journal of Pathology|August 14, 2013
MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasionEldo T Verghese, Ruth Drury, Caroline A Green, et al.
Scientific Reports|July 22, 2017
Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc <sup>Min/+</sup> mouse model of intestinal tumorigenesisMark A Hull, Richard J Cuthbert, C W Stanley Ko, et al.
Gut|September 28, 2017
A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiotaHenry Watson, Suparna Mitra, Fiona C Croden, et al.
International Journal of Cancer|January 10, 2019
Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance)Mingyang Song, Fang-Shu Ou, Tyler J Zemla, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2023
Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention TrialJohn R Davies, Tracey Mell, Harriett Fuller, et al.
Pageof 9